GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ENSC · Jun 30, 2025

Ensysce Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001641172-25-023512General Corporate
Operating cash generation75thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-197.37% · OPTIONAL · VALID

Revenue growth88thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

654.38% · CORE · VALID

Operating margin92thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-127.64% · CORE · VALID

R&D intensity17thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

140.25% · OPTIONAL · VALID

SBC intensity25thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

6.61% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-129.37%
Current
-197.37%
Delta
-68.00%
Growth Increased
Previous
331.69%
Current
654.38%
Delta
322.69%
Profitability Increased
Previous
-149.08%
Current
-127.64%
Delta
21.44%
R And D Intensity Decreased
Previous
142.87%
Current
140.25%
Delta
-2.62%
Sbc Intensity Increased
Previous
1.23%
Current
6.61%
Delta
5.38%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.